[HTML][HTML] A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies

M Kumari, RM Lu, MC Li, JL Huang, FF Hsu… - Journal of biomedical …, 2022 - Springer
The novel coronavirus disease (COVID-19) pandemic remains a global public health crisis,
presenting a broad range of challenges. To help address some of the main problems, the …

[HTML][HTML] A comprehensive review of mRNA vaccines

V Gote, PK Bolla, N Kommineni, A Butreddy… - International journal of …, 2023 - mdpi.com
mRNA vaccines have been demonstrated as a powerful alternative to traditional
conventional vaccines because of their high potency, safety and efficacy, capacity for rapid …

[HTML][HTML] The use of RNA-based treatments in the field of cancer immunotherapy

M Chehelgerdi, M Chehelgerdi - Molecular Cancer, 2023 - Springer
Over the past several decades, mRNA vaccines have evolved from a theoretical concept to a
clinical reality. These vaccines offer several advantages over traditional vaccine techniques …

[HTML][HTML] COVID-19, post-acute COVID-19 syndrome (PACS,“long COVID”) and post-COVID-19 vaccination syndrome (PCVS,“post-COVIDvac-syndrome”): Similarities …

F Scholkmann, CA May - Pathology-Research and Practice, 2023 - Elsevier
Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

[HTML][HTML] Current evidence in SARS-CoV-2 mRNA vaccines and post-vaccination adverse reports: knowns and unknowns

DS Mouliou, E Dardiotis - Diagnostics, 2022 - mdpi.com
The novel mRNA vaccinations against COVID-19 are gaining worldwide attention for their
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …

[HTML][HTML] COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19

S Shibata, K Kobayashi, M Tanaka, K Asayama… - Hypertension …, 2023 - nature.com
The number of reported cases with coronavirus disease 2019 (COVID-19) has exceeded
620 million worldwide, still having a profound impact on people's health and daily lives since …

[HTML][HTML] Molecular mimicry of the viral spike in the SARS-CoV-2 vaccine possibly triggers transient dysregulation of ACE2, leading to vascular and coagulation …

CA Devaux, L Camoin-Jau - Viruses, 2023 - mdpi.com
The benefits of SARS-CoV-2 spike mRNA vaccines are well known, including a significant
decline in COVID-19 morbidity and a decrease in the mortality rate of SARS-CoV-2 infected …

[HTML][HTML] COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)

B Zhang, X Yu, J Liu, J Liu, P Liu - BMC Women's Health, 2022 - Springer
Background In reports of adverse reactions following vaccination with the coronavirus
disease 2019 (COVID-19) vaccines, there have been fewer reports of concern for menstrual …

[HTML][HTML] Ocular vascular events following COVID-19 vaccines: a systematic review

H Abu Serhan, A Abdelaal, MT Abuawwad, MJJ Taha… - Vaccines, 2022 - mdpi.com
The main aim of this study is to investigate the current evidence regarding the association
between COVID-19 vaccination and ocular vascular events. The protocol is registered on …

Distinct features of vascular diseases in COVID-19

A Ceasovschih, V Sorodoc, A Shor… - Journal of …, 2023 - Taylor & Francis
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic was declared in early 2020
after several unexplained pneumonia cases were first reported in Wuhan, China, and …